IQVIA’s FluSTAR Online Dynamic Platform Helps Consumers Track Local Rates of Flu, Allergy and Asthma
March 04 2019 - 3:15PM
Business Wire
IQVIA uses advanced analytics and innovative
technology, to find medium-to-high rates of flu in multiple U.S.
markets; highest levels in parts of Montana, Nebraska and Texas
IQVIA™ (NYSE:IQV), a leader in human data science, provides
consumers with quick and easy access to seasonal suffering data,
giving them unique insights into important health related
information. Recent data show that flu season is hitting hard in
several key markets.
IQVIA monitors seasonal suffering across the U.S. and provides
key healthcare measurements for flu, allergy, and cough and cold
season. Powered by the IQVIA CORE™, unparalleled data and advanced
analytics capabilities, IQVIA provides detailed information on
levels of impact, identification of most affected U.S. cities, and
a breakdown between pediatric and adult populations in each
market.
IQVIA’s proprietary platform, www.FluSTAR.com, provides cold and
flu forecast information for every ZIP code in the country. FluSTAR
allows health care professionals and consumers to see the most
up-to-date information on the spread of the flu during each
influenza season. Data are gathered through different surveillance
methods including rapid assay data, laboratory confirmation, and
clinical diagnosis data. This surveillance allows a regional and
national picture of influenza activity to be generated.
As of mid-February, FluSTAR indicated medium-high or high rates
of flu in multiple markets throughout the country with the highest
levels captured in Southwest Montana, Western Nebraska and in Del
Rio, Texas. Nationally, flu numbers continued to rise throughout
February and in March flu numbers should decline to the early
February numbers.
“IQVIA’s unparalleled data gives us the ability to monitor
seasonal suffering across the U.S.,” said Chris Nickum, vice
president, general manager, Primary Intelligence at IQVIA. “We are
able to track and forecast the cold, flu, and allergy season with a
high degree of accuracy.”
IQVIA also provides asthma and allergy information at
www.AsthmaForecast.com. This includes the four-day Asthma Forecast
and daily Air Quality Index which are available for every U.S. ZIP
code. This free online resource also provides access to current
asthma news, as well as two years of archived asthma-related
articles.
IQVIA’s proprietary platform at www.Pollen.com provides daily
allergy severity forecasts that show upcoming airborne allergen
conditions by ZIP code. IQVIA developed Pollen.com’s proprietary
forecasts and manufactures Rotorod® the leading tool for pollen
count measurement. Rotorod has been used to collect pollen across
the country for over 30 years.
About IQVIAIQVIA (NYSE:IQV) is a leading global provider
of advanced analytics, technology solutions and contract research
services to the life sciences industry. Formed through the merger
of IMS Health and Quintiles, IQVIA applies human data science —
leveraging the analytic rigor and clarity of data science to the
ever-expanding scope of human science — to enable companies to
reimagine and develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
Click here to subscribe to Mobile Alerts for IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190304005968/en/
Tor Constantino, IQVIA Media Relations
(tor.constantino@iqvia.com)+1.484.567.6732
Andrew Markwick, IQVIA Investor Relations
(andrew.markwick@iqvia.com)+1.973.257.7144
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jun 2024 to Jul 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Jul 2023 to Jul 2024